HIT Consultant August 5, 2024
Jasmine Pennic

What You Should Know:

venBio, a leading life sciences venture capital firm, announced the successful closing of its fifth fund, venBio Fund V, with over $528M in capital commitments.

– The new fund will focus on investing in biopharmaceutical companies developing innovative treatments for unmet medical needs.

venBio Fund V Focus

With a strong track record of successful investments in companies such as Labrys...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Investments, Pharma / Biotech, Trends
The essential biotech news stories of the day
Sun Pharma buys Checkpoint and its new cancer drug
Beam launches $500m financing on base-editing trial data
British scientists unveil world-leading technology to speed up drug discovery
Pharma Pulse 3/10/25: Streamlining Prescription Processes, Marty Makary Grilled at Senate Confirmation Hearing & more

Share This Article